Revolution Medicines RVMD
NASDAQ RVMD
$208.81 -2.06 (-0.98%)
As of: Sep 4, 2026 · 2:30 PM EDT

Revolution Medicines (RVMD) Net Margin (QoQ) (2019 - 2023)

Analysis

Revolution Medicines (RVMD) Net Margin (QoQ) (2019 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn
10 Incyte 25.59 Bn 21.05 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -159,967.00
Mar 31, 2023 -60,228.00
Dec 31, 2022 181,641.00
Sep 30, 2022 -151,342.00
Jun 30, 2022 8,913.00
Mar 31, 2022 -20,389.00
Dec 31, 2021 425,153.00
Sep 30, 2021 -429,906.00
Jun 30, 2021 -14,235.00
Mar 31, 2021 2,391.00
Dec 31, 2020 -17,586.00
Sep 30, 2020 5,647.00
Jun 30, 2020 -8,320.00
Mar 31, 2020 -3,236.00
Dec 31, 2019 -1,946.00
Sep 30, 2019 -2,912.00
Jun 30, 2019 -1,006.00